Zensar Technologies Q2 Profit Rises to Rs 190 Crore; Approves M3BI Merger

TECHNOLOGY
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Zensar Technologies Q2 Profit Rises to Rs 190 Crore; Approves M3BI Merger

Zensar Technologies reported consolidated revenue of Rs 1,585.2 crore and net profit of Rs 190.2 crore for Q2 FY27. Alongside earnings, the board approved the merger of M3BI India Private Limited into the company, set to take effect from April 1, 2027.

Zensar Technologies Q2 Profit Hits Rs 190 Crore; Merger Approved

Consolidated revenue stood at Rs 1,585.2 crore, with net profit after tax reaching Rs 190.2 crore.

Reader Takeaway: Steady quarterly profit growth alongside a strategic internal merger designed to streamline corporate structure by 2027.

What just happened

Zensar Technologies has released its financial results for the quarter ended September 30, 2026. The company reported consolidated revenue of Rs 1,585.2 crore, up from Rs 1,508.3 crore in the preceding quarter. Net profit rose to Rs 190.2 crore from Rs 183.8 crore. Additionally, the board of directors officially approved the merger of its subsidiary, M3BI India Private Limited, into the parent entity.

Why this matters

The steady increase in quarterly consolidated earnings reflects stable operational performance. The merger approval is a significant structural move aimed at consolidation. By integrating M3BI India, the company seeks to align its internal operations more closely, though the financial impact of this integration is scheduled to materialize following the April 1, 2027 effective date.

What changes now

For the immediate term, there is no change to the operational structure of the company. Investors should watch for further updates regarding statutory and regulatory approvals required to finalize the merger process. The standalone numbers, which showed a profit of Rs 172.2 crore, highlight the difference between parent-level performance and consolidated group figures.

What to track next

Shareholders should monitor the progress of the merger through upcoming regulatory filings and the company's ability to maintain its margin profile in the subsequent quarters leading up to the April 2027 effective date.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.